Aditi Shastri, MD: Clinicians Need to ‘Come Together’ on TP53-Mutated MDS
The HemOnc Pulse
00:00
Subclassifying Patients with Low-Risk and High-Risk MDS
This chapter explores the subclassification of low-risk and high-risk MDS patients, discussing the evolution of prognostic tools and the availability of a web calculator for risk stratification based on clinical variables and genomic profiling data.
Transcript
Play full episode
